Malaria research and development: an assessment of global investment
This report presents the results of a survey of investment in malaria research and development in 2004. Data was collected from approximately 80 organizations, including the 14 presumed largest global funders and most of the 50 contributors believed to invest at least one million dollars annually. It was found that $323 million was invested in 2004, 56% by the public sector; the 2 largest funders were the US National Institute of Allergy and Infectious Diseases and the Bill & Melinda Gates Foundation, which contributed 49% of the total between them. 27% was spent by the funding agancies themselves and the rest granted to other organizations. The percentages spent on drugs, vaccines, implementation research, basic research, vector control and diagnostics were 37%, 24%, 17%, 16%, 4% and 1% respectively. Spending had approximately doubled since 1993, largely due to the 2 organizations mentioned above, but remained low relative to the disease burden.
Published by Program for Appropriate Technology in Health, 2005; 52 pp.